Society Collaborations

The International Cell Death Society (ICDS) promulgates research and clinical information on the broad topic of cell death, including apoptosis, autophagy, necrosis, necroptosis, and other variants. ICDS brings together researchers from varying backgrounds and countries to foster international cooperation and collaborations based on new and different ideas.

ICDS started as a club in 1995, based on the intellectual and personal compatibility of a group of researchers from very different backgrounds working in the New York metropolitan area.

The meetings organised by ICDS are their most important annual events. They serve as the most visible example of the Society’s efforts to promote interaction and collaboration between scientists working in various subspeciality fields of apoptosis.

There is no comparable US-based society that formally recognises the need for such a rapidly growing area. For more information about ICDS, please visit their website at https://celldeath-apoptosis.org/.

The Nordic Autophagy Society (NAS) is a non-profit academic society that aims to promote excellent, innovative, and ground breaking research in the field of autophagy in the Nordic-Baltic countries (Norway, Sweden, Finland, Denmark, Iceland, Estonia, Latvia, and Lithuania) and the Netherlands.

NAS stems from the Nordic Autophagy Network, which was established in 2011 and, from 2015 onward, has gradually transitioned into a society, resulting in the formal foundation of NAS in January 2018.

NAS organizes annual conferences with internationally esteemed keynote speakers, provides lab exchange and conferences grants, and maintains an active website with relevant information and news stories for both members and non-members. NAS is open for individual memberships from residents of all countries (not only membership countries). 

The GETH‑TC is a multidisciplinary scientific society committed to improving clinical outcomes in hematopoietic stem cell transplantation (HSCT) and cellular therapy for patients with immuno‑hematologic diseases. As the Spanish reference organization in the field of lympho‑hematopoietic cellular therapy and its associated conditions, it aims to serve as a central meeting point for patients, the scientific community, and other stakeholders.

To fulfill its mission, GETH‑TC promotes a wide range of initiatives, including scientific projects such as clinical trials, real‑world evidence studies, and clinical registries; educational and outreach activities including specialized courses, continuing training, meetings, and publications; quality‑focused programs such as clinical guidelines, HSCT accreditation reference programs; and consulting and policy‑shaping work in coordination with related organizations and public administrations.

The SEHH is a scientific society purposed with the promotion, development and dissemination of research advances in two specialist areas, Hematology and Hemotherapy. In particular, the SEHH focuses on their medical, scientific, organizational, care, teaching and research aspects. Hematology, as a specialty, covers all aspects related to the physiology of the blood and hematopoietic organs, the diagnosis and treatment of benign and malignant diseases of the blood, the study of the hemostasis and coagulation system, and all aspects related to transfusion medicine, including hematopoietic stem cell transplantation. The professional role of the hematologist covers all aspects of the practice.

With 61 years of history, the SEHH is today an organization that contributes significantly to science. At present, it holds a community of almost 2800 professionals, of which many are internationally recognized figures, who continually contribute to making hematology, globally, one of the most prestigious fields of Spanish medicine. The society considers that for optimal patient care, it is essential to have access to medical advances, promote research and have well-trained and highly qualified specialists in the management of hematological diseases.